Drug
Esomeprazole
Esomeprazole: highest development phase Approved, developed by AstraZeneca, Krka, Viatris. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- AstraZeneca, Krka, Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACID REDUCER | Approved | |
| Esomeprazole (Nexium) NCT00241501 | Phase 3 | Gastroesophageal Reflux Disease (GERD) |
| Esomeprazole 40mg, Clarithromycin 500 mg, Metronidazole 400 mg, NCT04359966 | Not Applicable | Helicobacter Pylori Infection |
Latest
No recent events.
Follow Esomeprazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.